This report studies the Atrial Fibrillation Devices market. Atrial fibrillation (also called AFib or AF) is a quivering or irregular heartbeat (arrhythmia) that can lead to blood clots, stroke, heart failure and other heart-related complications. Atrial Fibrillation Devices are the devices used for atrial fibrillation therapy, including access, diagnostic, visualization and ablation products to assist physicians in diagnosing and treating various irregular heart rhythms.
Due to the COVID-19 pandemic, the global Atrial Fibrillation Devices market size is estimated to be worth US$ 3130.2 million in 2021 and is forecast to a readjusted size of US$ 5576.8 million by 2028 with a CAGR of 8.6% during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Atrial Fibrillation Devices market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Atrial Fibrillation Devices landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
The leading manufacturers of atrial fibrillation devices include Johnson & Johnson, Boston Scientific, Abbott, Medtronic, Japan Lifeline, and Atricure, with the top three accounting for about 65%.
North America is the largest market with about 35%, followed by Europe with about 30%.
This report focuses on Atrial Fibrillation Devices volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Atrial Fibrillation Devices market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, South America and Middle East & Africa, etc.
Global Atrial Fibrillation Devices Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Catheter Ablation
Maze Surgery
Segment by Application
Hospitals
Ambulatory Surgical Centers
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
Johnson & Johnson
Abbott
Medtronic
Japan Lifeline
Boston Scientific
Atricure
Biotroik
OSYPKA
Cardiofocus
MicroPort EP MedTech
Synaptic Medical